# Positron Emission Tomography in Monitoring Treatment Response in Women With Newly Diagnosed Breast Cancer

> **NCT01018251** · NA · WITHDRAWN · sponsor: **Abramson Cancer Center at Penn Medicine**

## Conditions studied

- Adult Women With a New Diagnosis of Invasive Breast Cancer (Have Not Undergone Treatment)

## Interventions

- **OTHER:** 3'-deoxy-3'-[18F]fluorothymidine
- **PROCEDURE:** Positron Emission Tomography/computed tomography
- **RADIATION:** FLT-PET/CT

## Key facts

- **NCT ID:** NCT01018251
- **Lead sponsor:** Abramson Cancer Center at Penn Medicine
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2009-03
- **Primary completion:** 2011-06
- **Final completion:** 2011-06
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2015-12-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01018251

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01018251, "Positron Emission Tomography in Monitoring Treatment Response in Women With Newly Diagnosed Breast Cancer". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT01018251. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*